Controlling the levels of oxidative DNA damage improves patient’s response to simvastatin therapy in primary male infertility

  • Ahmed S. Al-Hilli College of Medicine, University of Kufa, Iraq.
  • Najah A. Hadi Department of Pharmacology, College of Medicine, University of Kufa, Iraq.
  • Ala’a S. Ali Dermatology & Venereology Specialist, Al-Hakeem Hospital, Najaf, Iraq.
  • Dina A. Jamil School of Medicine, Faculty of Health, University of Tasmania, Tasmania, Australia.
  • Hayder A. Al-Aubaidy School of Medicine, Faculty of Health, University of Tasmania, Tasmania, Australia.


Objectives Male primary infertility can occur for several reasons. In most of the cases, sperm sample examination itself may give informationabout the underlying cause, but it would not help in determining the management plan. Simvastatin treatment can help to reduce thedegree of oxidative stress and improve sperm outcome. 8-hydroxydeoxyguanosine (8-OHdG) is a marker of oxidative DNA damage thatcan be used to assess the level of oxidative stress and the patient’s response to a course of treatment.Methods This is a randomized controlled trial study, which included 90 participants (55 males with primary infertility and a matching of 35control subjects). The patients were recruited from Al-Najaf Teaching Hospital, Iraq. Patients were provided with simvastatin tablets (20 mg× once daily for 12 weeks). Semen samples were taken to assess sperm parameters such as morphology, motility and motility. In addition,urinary samples were also collected to measure levels of 8-OHdG, before and after the simvastatin treatment course.Results This study showed significant reduction in the levels of urinary 8-OHdG in the patient group compared to the control group afterthe treatment course.Conclusion This study provides evidence about the beneficial use of simvastatin to improve the sperms’ outcome in males with primaryinfertility. In addition, the useful measurement of urinary 8-OHdG is to monitor the degree of oxidative stress and patient’s response tomedication.
share this Article by


1. Larsen U. Research on infertility: which definition should we use? Fertil Steril. 2005;83:846–852.
2. Köhn FM, Schuppe HC. [Male infertility–pathogenic factors]. MMW Fortschr Med. 2014;156:40–43.
3. Ko EY, Sabanegh ES Jr., Agarwal A. Male infertility testing: reactive oxygen species and antioxidant capacity. Fertil Steril. 2014;102:1518–1527.
4. Wang X, Sharma RK, Gupta A, George V, Thomas AJ, Falcone T, et al. Alterations in mitochondria membrane potential and oxidative stress in infertile men: a prospective observational study. Fertil Steril. 2003;80:844–850.
5. Pahune PP, Choudhari AR, Muley PA. The total antioxidant power of semen and its correlation with the fertility potential of human male subjects. J Clin Diagn Res. 2013;7:991–995.
6. Guerriero G, Trocchia S, Abdel-Gawad FK, Ciarcia G. Roles of reactive oxygen species in the spermatogenesis regulation. Front Endocrinol (Lausanne). 2014;5:56.
7. Al-Aubaidy HA, Jelinek HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010;15:155–160.
8. Schisterman EF, Mumford SL, Chen Z, Browne RW, Boyd Barr D, Kim S, et al. Lipid concentrations and semen quality: the LIFE study. Andrology 2014;2:408–415.
9. Sahreen S, Khan MR, Khan RA, Shah NA. Effect of Carissa opaca leaves extract on lipid peroxidation, antioxidant activity and reproductive hormones in male rats. Lipids Health Dis. 2013;12:90.
10. Takayama M, Matsubara M, Arakawa E, Takada C, Ina Y, Hasegawa K, et al. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits. Vascul Pharmacol. 2007;46:302–308.
11. Evenson DP, Jost LK, Marshall D, Zinaman MJ, Clegg E, Purvis K, et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod. 1999;14:1039–1049.
12. Al-Aubaidy H, Jelinek H. Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus. Br J Diabetes Vasc Dis. 2011;11:87–91.
13. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011;164:899–904.
14. Al-Aubaidy HA, Sahib HA, Mohammad BI, Hadi NR, Abas SM. Antiatherosclerotic potential of aliskiren: its antioxidant and antiinflammatory effects in rabbits: a randomized controlled trial. J Pharm Technol Drug Res. 2013;2:1–6.
15. Zaneveld L, Polakpski K. Collection and physical examination of the ejaculate. In: Techniques of Human Andrology: Hafez ESE (Ed.), 1977, 156–171, North-Holland Biomedical Press, Elsevier.
16. Shekarriz M, Sharma RK, Thomas AJ, Agarwal A. Positive myeloperoxidase staining (Endtz test) as an indicator of excessive reactive oxygen species formation in semen. J Assist Reprod Genet. 1995;12:70–74.
17. Dandekar SP, Parkar GM. Correlation between creatine kinase activity, lipid-peroxidation and water test in male infertility. J Postgrad Med. 1999;45:42–48.
18. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:F948–F957.
19. Jamil D, Al-Aubaidy H, Smith L, Jelinek H. Oxidative DNA damage in gestational diabetes mellitus: correlation with antioxidants in an Iraqi cohort. Int J Biochem Res Rev. 2014;4:410–419.
20. Ko SH, Park JH, Kim SY, Lee SW, Chun SS, Park E. Antioxidant Effects of spinach (Spinacia oleracea L.) supplementation in hyperlipidemic Rats. Prev Nutr Food Sci. 2014;19:19–26.
21. Aziz N, Saleh RA, Sharma RK, Lewis-Jones I, Esfandiari N, Thomas AJ et al. Novel association between sperm reactive oxygen species production, sperm morphological defects, and the sperm deformity index. Fertil Steril. 2004;81:349–354.
How to Cite
AL-HILLI, Ahmed S. et al. Controlling the levels of oxidative DNA damage improves patient’s response to simvastatin therapy in primary male infertility. Iraq Medical Journal, [S.l.], v. 2, n. 3, p. 61-63, sep. 2018. ISSN 2521-8492. Available at: <>. Date accessed: 20 nov. 2018.